GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 32 filers reported holding GALERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,000 | -91.2% | 35,092 | +59.9% | 0.00% | – |
| Q2 2023 | $68,000 | +161.5% | 21,943 | +121.9% | 0.00% | – |
| Q1 2023 | $26,000 | +136.4% | 9,888 | +28.4% | 0.00% | – |
| Q4 2022 | $11,000 | -31.2% | 7,700 | -19.0% | 0.00% | – |
| Q3 2022 | $16,000 | +33.3% | 9,504 | +3.2% | 0.00% | – |
| Q2 2022 | $12,000 | -45.5% | 9,210 | -0.5% | 0.00% | – |
| Q1 2022 | $22,000 | -51.1% | 9,253 | -6.3% | 0.00% | – |
| Q4 2021 | $45,000 | -27.4% | 9,875 | +28.2% | 0.00% | – |
| Q3 2021 | $62,000 | +1966.7% | 7,700 | +2611.3% | 0.00% | – |
| Q2 2021 | $3,000 | -57.1% | 284 | -62.6% | 0.00% | – |
| Q1 2021 | $7,000 | +40.0% | 760 | +69.6% | 0.00% | – |
| Q4 2020 | $5,000 | – | 448 | +7366.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 6 | -99.1% | 0.00% | – |
| Q1 2020 | $7,000 | +600.0% | 698 | +591.1% | 0.00% | – |
| Q4 2019 | $1,000 | – | 101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $913,702 | 0.63% |
| SECTORAL ASSET MANAGEMENT INC | 1,666,666 | $2,483,332 | 0.48% |
| Sofinnova Investments, Inc. | 3,083,712 | $4,594,731 | 0.27% |
| Novo Holdings A/S | 2,459,021 | $3,663,941 | 0.23% |
| Tekla Capital Management LLC | 898,374 | $1,338,577 | 0.05% |
| Blackstone Inc. | 1,678,984 | $2,501,686 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 187,000 | $278,630 | 0.01% |
| Ensign Peak Advisors, Inc | 151,777 | $226,148 | 0.00% |
| TCI Wealth Advisors, Inc. | 6,162 | $9,181 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,819 | $27 | 0.00% |